Subscribe to RSS Feed
Medicines-Diabetes Treatment-Veropharm-Boiron-Talion-A-PharmSintez-AstraZeneca-Renewal-EndoPharm-Sanofi-NovoNordisk-Valenta-Zentiva-GSK-Kanonfarma-Shering-Plau-Belupo-Lannacher-Sandoz-Kamelia-Italfarmaco-Lek-SUNpharma-UPSA-Dompe-Simpex-Chauvin Ankerpharm-Hyperion-Hexal-Avexima-НПЦРИЗ-Canada Peptides-Фармстандарт-Лексредства ОАО
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-Veropharm-Boiron-Talion-A-PharmSintez-AstraZeneca-Renewal-EndoPharm-Sanofi-NovoNordisk-Valenta-Zentiva-GSK-Kanonfarma-Shering-Plau-Belupo-Lannacher-Sandoz-Kamelia-Italfarmaco-Lek-SUNpharma-UPSA-Dompe-Simpex-Chauvin Ankerpharm-Hyperion-Hexal-Avexima-НПЦРИЗ-Canada Peptides-Фармстандарт-Лексредства ОАО
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
Veropharm
Boiron
Talion-A
PharmSintez
AstraZeneca
Renewal
EndoPharm
Sanofi
NovoNordisk
Valenta
Zentiva
GSK
Kanonfarma
Shering-Plau
Belupo
Lannacher
Sandoz
Kamelia
Italfarmaco
Lek
SUNpharma
UPSA
Dompe
Simpex
Chauvin Ankerpharm
Hyperion
Hexal
Avexima
НПЦРИЗ
Canada Peptides
OTCPharm JSC
- The purpose of the medication
- Manufacturer
